Abstract

Identification of emerging synthetic designer drugs is challenging in the absence of reference materials for subsequent mass spectral comparison. In this work, linear discriminant analysis (LDA) models were developed and validated for the characterization of compounds according to structural class based on mass spectral features. A set of synthetic phenethylamines and tryptamines was analyzed by gas chromatography-mass spectrometry (GC–MS) and the resulting spectra were probed to identify characteristic variables (m/z values) for model development. Two approaches were used to select characteristic variables. First, ions known to be characteristic of each compound class were selected, resulting in a total of 13 variables that were used to develop an LDA model. Following cross validation of the model, a test set of phenethylamines and tryptamines was classified, resulting in a successful classification rate of 93%. In the second approach, principal components analysis (PCA) was used as a more objective method for variable selection. With this approach, a total of 9 variables were selected and the resulting LDA model generated a successful classification rate of 86%.While the classification success of each LDA model was similar, the PCA method for variable selection is substantially less time consuming than the more detailed approach that requires probing mass spectra for characteristic features. Classification models such as those reported here have potential utility for the class characterization of emerging analogs for which reference materials are not yet available.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call